BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9040936)

  • 21. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
    IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BPV-4 E8 transforms NIH3T3 cells, up-regulates cyclin A and cyclin A-associated kinase activity and de-regulates expression of the cdk inhibitor p27Kip1.
    O'Brien V; Campo MS
    Oncogene; 1998 Jul; 17(3):293-301. PubMed ID: 9690511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
    Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence.
    Johnson D; Frame MC; Wyke JA
    Oncogene; 1998 Apr; 16(15):2017-28. PubMed ID: 9591786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
    Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF
    Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.
    Pérez de Castro I; Benet M; Jiménez M; Alzabin S; Malumbres M; Pellicer A
    Cancer Res; 2005 Apr; 65(8):3249-56. PubMed ID: 15833857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
    Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
    Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The uteroglobin promoter targets expression of the SV40 T antigen to a variety of secretory epithelial cells in transgenic mice.
    Sandmöller A; Halter R; Gómez-La-Hoz E; Gröne HJ; Suske G; Paul D; Beato M
    Oncogene; 1994 Oct; 9(10):2805-15. PubMed ID: 8084586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of cell growth, p34cdc2 and cyclin A levels by SV-40 large T antigen.
    Oshima J; Steinmann KE; Campisi J; Schlegel R
    Oncogene; 1993 Nov; 8(11):2987-93. PubMed ID: 8414501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of viral and cellular genes in papillomas of the choroid plexus induced in transgenic mice.
    Marks J; Lin J; Miller D; Lozano G; Herbert J; Levine AJ
    Prog Clin Biol Res; 1988; 284():163-86. PubMed ID: 2851142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced levels of alpha1(XI) procollagen mRNA in SV40-transformed cells.
    Sompayrac L; Jane S; Danna KJ
    Virology; 1996 Apr; 218(2):412-6. PubMed ID: 8610470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental analysis of bone tumors in polyomavirus transgenic mice.
    Wang R; Siegal GP; Scott DL; Bautch VL
    Lab Invest; 1994 Jan; 70(1):86-94. PubMed ID: 8302023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cell transformation].
    Monier R
    Rev Prat; 1995 Oct; 45(15):1867-72. PubMed ID: 8525294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inducible transformation of cells from transgenic mice expressing SV40 under lac operon control.
    Epstein-Baak R; Lin Y; Bradshaw V; Cohn M
    Cell Growth Differ; 1992 Feb; 3(2):127-34. PubMed ID: 1504017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung tumourigenesis in a conditional Cul4A transgenic mouse model.
    Yang YL; Hung MS; Wang Y; Ni J; Mao JH; Hsieh D; Au A; Kumar A; Quigley D; Fang LT; Yeh CC; Xu Z; Jablons DM; You L
    J Pathol; 2014 Jun; 233(2):113-23. PubMed ID: 24648314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The creation of diet-dependent cancer models using transgenesis in animals].
    Cartier N; Briand P; Kahn A
    Ann Gastroenterol Hepatol (Paris); 1994 Sep; 30(4):175-9; discussion 180. PubMed ID: 7979151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation.
    Ahuja D; Sáenz-Robles MT; Pipas JM
    Oncogene; 2005 Nov; 24(52):7729-45. PubMed ID: 16299533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Spontaneous differentiation of cultured human pulmonary adenocarcinoma cells].
    Timofeevskaia EA; Viadro MM; Tikhomirova EE; Avdeev GI; Romanova TI
    Biull Eksp Biol Med; 1983 Apr; 95(4):68-9. PubMed ID: 6831022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and characterization of a conditionally immortalized lung clara cell line from the H-2Kb-tsA58 transgenic mouse.
    Demello DE; Mahmoud S; Ryerse J; Hoffmann JW
    In Vitro Cell Dev Biol Anim; 2002 Mar; 38(3):154-64. PubMed ID: 12026164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.